FDA Inspection 957148 — Kobyashi Healthcare International

Kobyashi Healthcare International — FEI 1527608

The FDA completed an inspection of Kobyashi Healthcare International on Feb 1, 2016 in Poland, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 1, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Poland, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.